Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Cotta

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
European Urology|April 21, 2023
Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell CarcinomaBrittney H Cotta, Toni K Choueiri, Marcin Cieslik, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 4, 2019
Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectivesSean W Berquist, Kendrick Yim, Stephen T Ryan, et al.
Minerva Urology and Nephrology|August 5, 2020
Impact of positive surgical margins on survival after partial nephrectomy in localized kidney cancer: analysis of the National Cancer DatabaseStephen T Ryan, Devin N Patel, Fady Ghali, et al.
Urology|January 7, 2022
Disparities in Cancer Specific and Overall Survival Outcomes in African Americans With Renal Cell Carcinoma: Analysis From the International Marker Consortium for Renal Cancer (INMARC)Margaret F Meagher, Dattatraya Patil, Kazutaka Saito, et al.
BJU International|August 11, 2020
Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC)Brittney H Cotta, Margaret F Meagher, Dattatraya Patil, et al.
World Journal of Urology|February 3, 2019
Should partial nephrectomy be considered "elective" in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomyZachary A Hamilton, Umberto Capitanio, Brian R Lane, et al.
Urology|December 15, 2019
Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging CriteriaZachary A Hamilton, Umberto Capitanio, Deepak Pruthi, et al.
Clinical Genitourinary Cancer|February 28, 2019
Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative AnalysisCharles A Field, Brittney H Cotta, Juan Jimenez, et al.
The Journal of Urology|August 5, 2025
Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete MetastasectomyAli Ghasemzadeh, E Jason Abel, Jose A Karam, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
European Urology|April 21, 2023
Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell CarcinomaBrittney H Cotta, Toni K Choueiri, Marcin Cieslik, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 4, 2019
Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectivesSean W Berquist, Kendrick Yim, Stephen T Ryan, et al.
Minerva Urology and Nephrology|August 5, 2020
Impact of positive surgical margins on survival after partial nephrectomy in localized kidney cancer: analysis of the National Cancer DatabaseStephen T Ryan, Devin N Patel, Fady Ghali, et al.
Urology|January 7, 2022
Disparities in Cancer Specific and Overall Survival Outcomes in African Americans With Renal Cell Carcinoma: Analysis From the International Marker Consortium for Renal Cancer (INMARC)Margaret F Meagher, Dattatraya Patil, Kazutaka Saito, et al.
BJU International|August 11, 2020
Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC)Brittney H Cotta, Margaret F Meagher, Dattatraya Patil, et al.
World Journal of Urology|February 3, 2019
Should partial nephrectomy be considered "elective" in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomyZachary A Hamilton, Umberto Capitanio, Brian R Lane, et al.
Urology|December 15, 2019
Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging CriteriaZachary A Hamilton, Umberto Capitanio, Deepak Pruthi, et al.
Clinical Genitourinary Cancer|February 28, 2019
Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative AnalysisCharles A Field, Brittney H Cotta, Juan Jimenez, et al.
The Journal of Urology|August 5, 2025
Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete MetastasectomyAli Ghasemzadeh, E Jason Abel, Jose A Karam, et al.
Pageof 9